Poliovirus Receptor 抗体 (APC)
-
- 抗原 See all Poliovirus Receptor (PVR) 抗体
- Poliovirus Receptor (PVR)
-
适用
- 小鼠
-
宿主
- 大鼠
-
克隆类型
- 单克隆
-
标记
- This Poliovirus Receptor antibody is conjugated to APC
-
应用范围
- Flow Cytometry (FACS)
- 纯化方法
- Affinity purified
- 免疫原
- Mouse PVR
- 克隆位点
- TX56
- 亚型
- IgG2a
- Top Product
- Discover our top product PVR Primary Antibody
-
-
- 应用备注
-
Approved: Flo
Usage: This TX56 antibody has been tested by flow cytometric analysis on mouse thymocytes. This can be used at less than or equal to 1 μg per test. A test is defined as the amount (ug) of antibody that will stain a cell sample in a final volume of 100 μL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. - 说明
-
Target Species of Antibody: Mouse
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- aqueous buffer, 0.09 % sodium azide, may contain carrier protein/stabilizer
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Do not freeze. Product is photosensitive and should be protected from light.
- 储存条件
- 4 °C
- 储存方法
- Store at 4°C. Do not freeze. Protect from light.
-
- 抗原
- Poliovirus Receptor (PVR)
- 别名
- PVR / CD155 (PVR 产品)
- 别名
- PVR antibody, CD155 antibody, HVED antibody, NECL5 antibody, Necl-5 antibody, PVS antibody, TAGE4 antibody, 3830421F03Rik antibody, D7Ertd458e antibody, Taa1 antibody, Tage4 antibody, mE4 antibody, necl-5 antibody, poliovirus receptor antibody, PVR antibody, Pvr antibody
- 背景
-
Name/Gene ID: PVR
Synonyms: PVR, CD155, Hpvr, HVED, Nectin-like 5, Nectin-like protein 5, Poliovirus receptors beta, Poliovirus receptor, PVS, Necl-5, CD155 antigen, NECL5, TAGE4 - 基因ID
- 5817
- UniProt
- P15151
- 途径
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interactome
-